文献速递神经肿瘤小儿神经外科与脑积水

小脑脑桥角肿瘤治疗后发生交通性脑积水

Communicating Hydrocephalus Following Treatment of Cerebellopontine Angle Tumors.
PubMed 文献 · World Neurosurg · 2022-06-26

回顾性单中心队列研究纳入405例(286例神经鞘瘤、119例脑膜瘤),分析症状性交通性脑积水累积发生率。神经鞘瘤风险显著高于脑膜瘤(HR 4.70,95%CI 1.78-12.4,P=0.002);仅接受立体定向放射外科治疗的神经鞘瘤患者发生率10.6% vs 脑膜瘤1.4%(P=0.037)。Koos III级前庭神经鞘瘤患者手术切除较SRS更有利于预防脑积水(OR 0.089,95%CI 0.011-0.743,P=0.025)。

要点

  • 神经鞘瘤发生症状性交通性脑积水的风险显著高于脑膜瘤(HR 4.70)。
  • 仅接受SRS的神经鞘瘤患者脑积水发生率10.6%,脑膜瘤为1.4%。
  • Koos III级前庭神经鞘瘤患者手术切除较SRS降低脑积水风险(OR 0.089)。

核心结论

  • 症状性交通性脑积水在神经鞘瘤中比脑膜瘤更常见。
  • 在特定前庭神经鞘瘤亚组中,以肿瘤切除作为初始治疗可降低脑积水风险。

研究设计与样本

  • 本研究为回顾性单中心队列研究,共回顾405例,包括286例神经鞘瘤和119例脑膜瘤。
  • 评估神经鞘瘤和脑膜瘤患者症状性交通性脑积水的累积发生率。
  • 采用多变量Cox模型评估危险因素的风险比及不同治疗亚组的比值比。

主要发现

  • 神经鞘瘤的脑积水风险显著高于脑膜瘤(风险比4.70,95%置信区间1.78-12.4,P=0.002)。
  • 接受SRS而未行肿瘤切除的神经鞘瘤患者脑积水发生率显著高于脑膜瘤患者:10.6% vs 1.4%(P=0.037)。
  • Koos III级前庭神经鞘瘤患者接受肿瘤切除较接受SRS在预防脑积水方面获益更大(比值比0.089,95%置信区间0.011-0.743,P=0.025)。
  • 研究识别出仅接受SRS治疗时易增加脑积水风险的特定亚组。

关键数值与推荐

  • 神经鞘瘤 vs 脑膜瘤的脑积水风险:HR 4.70(95%CI 1.78-12.4,P=0.002)。
  • 仅SRS的神经鞘瘤 vs 脑膜瘤脑积水发生率:10.6% vs 1.4%(P=0.037)。
  • Koos III级前庭神经鞘瘤手术切除 vs SRS预防脑积水的OR:0.089(95%CI 0.011-0.743,P=0.025)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本研究为回顾性单中心队列研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to clarify the risk of communicating hydrocephalus in cerebellopontine angle tumors, focusing on distinct tumor types and treatment modalities, i.e., tumor resection and stereotactic radiosurgery (SRS). METHODS: This study was a retrospective single-center cohort study. The cumulative incidences of symptomatic communicating hydrocephalus in schwannoma and meningioma patients were evaluated. A multivariate Cox model was used to assess the hazard ratios for the risk factors and odds ratios of distinct treatment subgroups. RESULTS: A total of 405 cases, including 286 schwannomas and 119 meningiomas, were retrospectively reviewed. The risk of hydrocephalus was significantly higher in schwannomas than that in meningiomas (hazard ratio, 4.70 [95% confidence interval, 1.78-12.4, P = 0.002]). Patients with schwannomas who received SRS without tumor resection showed a significantly higher incidence than meningioma cases: 10.6% versus 1.4% (P = 0.037). We identified specific subgroups that were prone to increase the risk of hydrocephalus when treated with SRS alone. The result showed that patients with vestibular schwannoma of Koos grade III had a greater benefit from tumor resection than from SRS in preventing hydrocephalus (odds ratio, 0.089 [95% confidence interval, 0.011-0.743, P = 0.025]). CONCLUSIONS: Symptomatic communicating hydrocephalus is more frequent in schwannoma than that in meningiomas. Primary treatment with tumor resection lowers the risk of hydrocephalus in specific subgroups of vestibular schwannoma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kim J, Woo B, Ji S, et al. Communicating Hydrocephalus Following Treatment of Cerebellopontine Angle Tumors. World Neurosurg. 2022. PMID: 35760327. doi:10.1016/j.wneu.2022.06.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。